Delivery Order SPE2DB22D3501-SPE2DB25FWW31
- Not listed
- The Defense Logistics Agency awarded a $5,575.86 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Thalomid (thalidomide) 100 mg capsules in quantities of 28 units. The award is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 30, 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $405.88 to Amerisourcebergen Drug Corporation. The order is for 4561919108 THALITONE 15 MG TABLET 30S to be delivered to a facility in Conshohocken, Pennsylvania by August 24, 2023. Amerisourcebergen Drug Corporation will perform as the prime contractor, with its parent company listed as Amerisourcebergen Corporation. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $52,487.80 by the Defense Logistics Agency on August 28, 2025, for the supply of Revlimid 25 mg capsules (100-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, and will be performed at the awardee's Conshohocken location. The contract carries no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 16, 2025, for the supply of CAPLYTA 42 mg capsules in a quantity of 30 units. This firm fixed price delivery order, valued at $29,358.50 with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $52,575.49 to AmerisourceBergen Drug Corp for 100 capsules of REVLIMID 10 mg on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $35,501.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This non-competitive, non-set-aside delivery order was executed on November 14, 2025, with an ultimate completion date of the same day. The work will be performed at the contractor's corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $57,546.06 to AmerisourceBergen Drug Corp for the supply of Teriflunomide 14 mg tablets (30-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside provisions and is set for completion by November 14, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,035.05 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Qualipita 60 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $27,031.66 to AmerisourceBergen Drug Corp for 25 tablets of Tabloid 40 mg, with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11.3 thousand to AmerisourceBergen Drug Corp for the supply of Quelipita 60 mg tablets (30-count packages) on January 5, 2026, with an ultimate completion date of January 6, 2026. This firm fixed-price delivery order represents a competitively awarded non-set-aside contract and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWW31Delivery Order
The Defense Logistics Agency awarded a $5,290.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Thalomid 100 mg capsules (quantity: 28 units). This is a non-set-aside, competitively awarded contract with a completion date of September 5, 2025, with performance to take place at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle active through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's extensive portfolio of DLA contract awards encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime contractor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen Drug Corp delivers medical supplies to customers including the Defense Health Agency and U.S. Coast Guard, demonstrating its capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/14/25 |